Million tablets per year
At Rottendorf Pharma, we invest in state-of-the-art equipment and have first-class production facilities and technologies. Our workforce includes more than 1,300 experienced and skilled employees, including many formulation scientists and technicians. Our German manufacturing facilities comply with GMP, FDA, ANVISA requirements, among others.
Customers choose Rottendorf Pharma for its broad-based expertise and technical knowledge, competence in international regulatory requirements, high quality standards, state-of-the-art facilities and exceptional customer service.
Our commitment to take full ownership of our customers' technical and business processes is reflected in our Total Process Ownership (TPO©) service concept.
At the same time, in the technology area, we rely on the Total Technological Mastering (TTM) approach to reduce the technical requirements for the customer. This is complemented by the Total Supply Integrity (TSI) service concept to establish reliable supply chains and guarantee first-class product quality.
Rottendorf Pharma is following the goal of becoming the leading contract developer and manufacturer in the area of solid forms. We focus our attention on the customer and, in addition to our service concept, are particularly convincing due to our pharmaceutical technological expertise coupled with high delivery reliability and modern supply chain concepts. This enables us to minimize the total cost of outsourcing for our customers and makes us an attractive partner.
Dr. Silke Huster, Managing Director
We have the target to establish ourselves in the international CDMO market for solid dosage forms as contract developer and manufacturer as technology leader with the strongest customer orientation. Together with our service concepts we want to convince as a preferred business partner of the pharmaceutical industry.